E
Clinical-stage biotech developing EVX-101, a 5-HTP based adjunctive therapy for depression and obsessive-compulsive disorder.
At a glance
- HQ: RTP
- Sector: Biotech
- Stage: Growth
The rest of this record is behind a free account.
Founders, funding history, investor connections, and recent signals load on this page as soon as you sign in. Accounts open immediately, and I read every signup.